The rise of chronic diseases and number of patients with unmet medical needs as a result of an ageing population, lifestyle changes & urbanization has catalyzed the Life Sciences industry into action.
Read our eBook to discover how to develop more innovative, personalized, sustainable products that improve upon patient outcomes.
Precision medicine promises to revolutionize healthcare, with its key goal of providing the right treatment to the right patient at the right time and dose, and thus the potential of improving quality of life and helping to bring down healthcare costs.
Recent scientific breakthroughs and technological advancements have improved our disease knowledge and altered diagnosis and treatment approaches resulting in more precise, predictive, preventative and personalized healthcare that is customized for the individual patient. In addition, the big data revolution has provided an opportunity for Life Sciences companies to apply artificial intelligence and machine learning algorithms to mine vast data sets and virtual twin experiences enable companies to bridge the gap between the experimental and real worlds and enhance disease understanding.
Leveraging recent scientific breakthroughs and technological advancements to improve our understanding of disease pathogenesis and change the way we diagnose and treat the disease can help Life Sciences companies create more precise, predictable, and powerful personalized solutions.
The application of technology advancements to drive competitive advantage allows Life Sciences companies to:
Anticipate & reduce risk with enhanced portfolio management
Increase number of indications for existing products
Improved quality & efficacy
Castleman Disease Collaborative Network and MEDIDATA advance potential diagnosis and treatment options with omics data.
Life Sciences companies worldwide are under increasing pressure to improve the patient experience and outcome by accelerating the delivery of innovative therapies and solutions meeting previously unmet medical needs of the highest quality and efficacy.
The 3DEXPERIENCE® platform enables Life Sciences companies to create experiences to satisfy unmet medical needs and improve patient outcomes in global markets in one virtual environment (exploration, discovery, development, testing, commercialization) – with full visibility across their internal and external ecosystems.
With the 3DEXPERIENCE platform, Life Sciences companies can effectively develop and manage laboratory processes and specifications with a multi-disciplinary scientific modeling and simulation approach. The platform allows closing the loop between the real and the virtual world, consolidating real data from the bench, and empowering stakeholders with virtual simulations significantly reducing time to market – allowing patient access to the right treatment at the right time.
Named after the Greek goddess of recovery, IASO is a Dassault Systèmes showcase for the lifecycle of a combination product in oncology. From upstream thinking through commercialization, IASO demonstrates the value that Dassault Systèmes and the 3DEXPERIENCE can deliver to stakeholders challenged with bringing innovation to market in the form of combination products and transforming the patient experience.
David Fajenbaum, MD, MBA, MSc, is an Assistant Professor of Medicine at the University of Pennsylvania, Associate Director of the Penn Orphan Disease Center, Founding Director of…
Biotherapeutics have exploded onto the pharmaceutical R&D scene over the past two decades. Indeed, some of the most successful treatments over this time have been biologics, vastly improving patient outcomes for previously intractable diseases.
Marie Bachoc, Design Program Manager at GE HEALTHCARE, talks about how design is used to improve patient experience using digital innovation and technologies.
Otto Bock HealthCare GmbH implemented the 3DEXPERIENCE® platform and precisely modeled its advanced prosthetic hand – the Michelangelo - within a very short timeframe.
The 3DEXPERIENCE® platform along with CATIA Imagine and Shape provided Otto Bock the ability to design their prothese to be as natural as possible.
Discover Dassault Systèmes®' Life Sciences industry solutions aiming to improve patient and physician experience, and organizational business excellence.